Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAPAS study of targeted inhaled tobramycin in cystic fibrosis
NL-OMON41894Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tobramycin in cystic fibrosis (CF) and Pseudomonal infection (2 arms), sponsored by Erasmus MC. Primary endpoint: Change in FEF75. Started May 2015; status: recruiting.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on NL-OMON41894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41894.